Ronald W. Pero
Technik-/Wissenschafts-/F&E-Leiter bei RezGen5 Ltd.
Profil
Ronald W.
Pero is a Professor-Emeritus at the University of Lund.
He is also the Chief Scientific Officer at RezGen5 Ltd.
and a Founding Member of Campamed, Inc. and Deep South Partners LLC.
Previously, he was a Founding Member of Oncotelic Therapeutics, Inc. and Optigenex, Inc.
Aktive Positionen von Ronald W. Pero
| Unternehmen | Position | Beginn |
|---|---|---|
RezGen5 Ltd.
 RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda. | Technik-/Wissenschafts-/F&E-Leiter | - |
| University of Lund | Corporate Officer/Principal | - |
| Campamed, Inc. | Corporate Officer/Principal | - |
| Deep South Partners LLC | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Ronald W. Pero
| Unternehmen | Position | Ende |
|---|---|---|
| OPTIGENEX INC. | Corporate Officer/Principal | - |
| ONCOTELIC THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ONCOTELIC THERAPEUTICS, INC. | Health Technology |
| OPTIGENEX INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
RezGen5 Ltd.
RezGen5 Ltd. Pharmaceuticals: MajorHealth Technology RezGen5 Ltd. operates as a biopharmaceutical company, which focused on discovering and developing proprietary, orally available, small molecule drugs with the potential to treat diseases associated with ageing, including metabolic diseases such as Type 2 Diabetes, Alzheimer's and cardiovascular diseases. The company was founded by Stuart Garret on June 15, 2012 and is headquartered in Hamilton, Bermuda. | Health Technology |
| Campamed, Inc. | |
| Deep South Partners LLC |
